Join the club for FREE to access the whole archive and other member benefits.

Vincent Smith

Chief Technology Officer at Broken String Biosciences

Vincent has spent the last 19 years creating DNA sequencing technologies that have transformed life science research and healthcare. Prior to joining the team at Broken String he was VP of Technology at Exact Sciences Innovation. He arrived at Exact via their 2020 acquisition of Base Genomics, an Oxford-based startup developing novel DNA methylation analysis technology, where Vincent was CTO. From 2004 to 2020 he was at Solexa and then Illumina, where in his final role as Vice President of Core Consumable Development he led a global team responsible for developing assays and consumables for many of the most successful NGS platforms in the Industry including the Genome Analyser, MiSeq, HiSeq, NextSeq and NovaSeq platforms. Between 2004 and 2007 Vincent was one of the key scientists at Solexa and made critical contributions to the design & development of the sequencing chemistry that underpins Illumina Sequencing today. He holds an MA from Oxford University and a PhD from Imperial College London, both in Biochemistry.

Visit website: https://www.brokenstringbio.com/profile/vincent-smith-phd/

 vincent-smith-5a295510

See also

Broken String Biosciences

Advancing the progress of cell and gene therapies

Details last updated 15-Apr-2025

Vincent Smith is also referenced in the following:

Broken String Biosciences

Advancing the progress of cell and gene therapies